CoChat

Analysis of transcriptomic and proteomic profiles demonstrates improved Madin–Darby canine kidney cell function in a renal microfluidic biochip

Snouber, Leila Choucha, Letourneur, Franck, Chafey, Philippe, Broussard, Cedric, Monge, Matthieu, Legallais, Cécile, Leclerc, Eric · 2012 · Biotechnology Progress
Cited by 60

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

We have evaluated the influence of the microfluidic environment on renal cell functionality. For that purpose, we performed a time lapse transcriptomic and proteomic analysis in which we compared gene and protein expressions of Madin–Darby canine kidney cells after 24 h and 96 h of culture in both microfluidic biochips and plates. The transcriptomic and proteomic integration revealed that the ion transporters involved in calcium, phosphate, and sodium homoeostasis and several genes involved in H+ transporters and pH regulation were up‐regulated in microfluidic biochips. Concerning drug metabolism, we found Phase I (CYP P450), Phase II enzymes (GST), various multidrug resistance genes (MRP), and Phase III transporters (SLC) were also up‐regulated in the biochips. Furthermore, the study shows that those inductions were correlated with the induction of the Ahr and Nrf‐2 dependent pathways, which results in a global cytoprotective response induced by the microenvironment. However, there was no apoptosis situation or cell death in the biochips. Microfluidic biochips may thus provide an important insight into exploring xenobiotic injury and transport modifications in this type of bioartificial microfluidic kidney. Finally, the investigation demonstrated that combining the transcriptomic and proteomic analyses obtained from a cell “on chip” culture would provide a pertinent new tool in the mechanistic interpretation of cellular mechanisms for predicting kidney cell toxicity and renal clearance in vitro. © 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/btpr.743

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Solvent Compatibility of Poly(dimethylsiloxane)-Based Microfluidic Devices

    Lee, J. N., Park, C., & Whitesides, G. M. (2003) · Analytical Chemistry · doi:10.1021/ac0346712 · Cited by 2,643 · cited 1×

    “Of them, the first involves the release into the culture medium of a toxic monomer from the PDMS resulting in an inflammatory response.(32) However, the plate experiments were also covered with PDMS material and, in that case, we failed to observe induction of these genes.”
  • Cytochrome P450-mediated metabolism of estrogens and its regulation in human

    Tsuchiya, Y., Nakajima, M., & Yokoi, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.007 · Cited by 616 · cited 2×

    “Despite the fact that the expression of CYP1B1 is higher in various types of malignant tumors compared with normal tissues,(33,39) it has been proposed that CYP1B1 plays an important role in PAH carcinogenesis and estrogen metabolism.(33,40) To reconstruct a pertinent renal model, one of the most important requirement…”
    Background

Cited by

See all 60

Metadata

Authors
Snouber, L. C., Letourneur, F., Chafey, P., Broussard, C., Monge, M., Legallais, C., & Leclerc, E.
Venue
Biotechnology Progress
Publisher
Wiley
Published
2011-11-16
Volume
28
Issue
2
Pages
474-484
ISSN
  • 1520-6033 (ISSN-L)
  • 8756-7938
OpenAlex
W2071336555
Cited by
60
References
2
FWCI
2.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.